mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
4e-07 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
5e-07 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
5e-07 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
6e-07 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
6e-07 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
9e-07 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
1e-06 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
1e-06 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |